CareStart™

Covid-19 Antigen, A Rapid POC Test

Purchase Test

CareStart™ Covid-19 Antigen

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in anterior nares swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider.

  • FAST

    Detect active infection status in 10 minutes.

  • CONVENIENT

    No lab equipment or additional instrument required.

  • EASY TO USE

    Lower nasal swab collection enables comfortable specimen collection.

  • Manufactured in the USA

    Manufactured in the U.S. by a U.S. headquartered company

Point-Of-Care (POC) Designated Test

As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.

FDA EMERGENCY USE AUTHORIZATION (Revision 3/21)

IFU (INSTRUCTIONS FOR USE)

HCP (HEALTH CARE PROFESSIONALS)

PATIENTS

CareStart Testing Instructions

Bloomberg: FDA Approval for CareStart™

Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)

Reagents & Materials Provided

Kit Component / Amount Per Kit

Test Devices / 20 ct.
Assay buffer / 20 ct.
Extraction vials and caps / 20 ct.
Specimen collection swabs / 20 ct.
1 Positive and 1 Negative control swab
Instructions for Use / 1 ct.